After CCM intervention, the expression of Bcl-2 and ALDH2 mRNA in CCM group was significantly higher than that in HF group, while the expression of Bax and Caspase-3 mRNA was significantly lower (P<0.05). The gene discussed is CASP3; the disease is cerebral cavernous malformation.